A Phase III clinical trial involving 101 centers in 21 countries revealed the monoclonal antibody blinatumomab to be more effective than standard chemotherapy for treatment of advanced acute lymphoblastic leukaemia (ALL). Study findings were published in...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2luoGiN
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου